800 NORTH GLEBE RD, SUITE 500, ARLINGTON, VA
Announces Fourth Quarter 2025 Results and Full Year 2025 Results
Other Events
Material disclosure
Announces Third Quarter 2025 Results
Announces Strategic Divestiture of its Value-Based Primary Care Business
Material Contracts, News, Securities Holder Rights or Indentures
Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
FY 2024
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Notice of Exempt Offering of Securities
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership